Skip to main content
Clinical Trials/JPRN-UMIN000009170
JPRN-UMIN000009170
Completed
Phase 4

Evaluation of Cardiac Sympathetic Nerve Activity and Aldosterone Suppression in Patients With Decompensated Acute Heart Failure on the Treatment Containing Intravenous Atrial Natriuretic Peptide - ANP in Decompensated AHF

Kitakanto Cardiovascular Hospital0 sites200 target enrollmentOctober 23, 2012

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
decompensated acute heart failure
Sponsor
Kitakanto Cardiovascular Hospital
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 23, 2012
End Date
March 31, 2011
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kitakanto Cardiovascular Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Cardiogenic shock or hypotension 2\) History of myocardial infarction or coronary artery disease 3\) Severe heart failure requiring mechanical support (intraaortic balloon pumping, left ventricular assist device, or cardiac resynchronization therapy) 4\) Requiring heart transplantation

Outcomes

Primary Outcomes

Not specified

Similar Trials